Home
News
Interviews
Companies
Videos
Subscribe
The
Latest
The Latest
News
Lobe Sciences, Ltd. Enters Collaborative Clinical Research Agreement with Integrative Headache Medicine of New York to Study the Effects of L-130 in the Treatment of Chronic Cluster Headache
News
Small Pharma Reports Positive Top-line Results from Phase IIa Trial of SPL026 in Major Depressive Disorder
News
Psyence Group Completes Export of Pharma Grade Psilocybin Extract to UK
News
Lobe Sciences Provides Update For 2023 Milestones
More Articles
FEATURED
Awakn Life Sciences Initiates Investigative Study of Novel Formulation of (S)-ketamine to Assess Dissociative Effect
News
Psyence and Eden Labs Announce Extraction and Product Development Collaboration
News
Cognetivity Neurosciences' CognICA Platform Successfully Monitors Cognitive Performance in Alzheimer's Patients Receiving Disease-Modifying Therapy
Trending
#
News
Small Pharma Reports Positive Top-line Results from Phase IIa Trial of SPL026 in Major Depressive Disorder
#
News
Algernon Pharmaceuticals Forms Private Subsidiary to Advance Company’s Psychedelic DMT Stroke Program
#
News
Tryp Therapeutics and Massachusetts General Hospital Sign Letter of Intent for Clinical Study Investigating the Use of Psilocybin-Assisted Psychotherapy for the Treatment of Patients Suffering From Irritable Bowel Syndrome (IBS)
#
News
Algernon NeuroScience Doses First Subject in Phase 1 DMT Clinical Stroke Study
#
News
Universal Ibogaine Highlights 2022 Accomplishments
Companies
#
ATAI Life Sciences
NEO
NASDAQ
ATAI
CSE
TSXV
Private Company
Non-Profit
#
Compass Pathways
NEO
NASDAQ
CMPS
CSE
TSXV
Private Company
Non-Profit
#
Algernon Pharmaceuticals
NEO
NASDAQ
CSE
AGN
TSXV
Private Company
Non-Profit
#
Mind Medicine (MindMed)
NEO
MMED
NASDAQ
MNMD
CSE
TSXV
Private Company
Non-Profit
#
Cybin Inc.
NEO
CYBN
NASDAQ
CSE
TSXV
Private Company
Non-Profit
